You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a reader survey, researchers and core lab staff share how they think cores are doing.
An integrated proteogenomic analysis led to previously unappreciated treatment targets or prognostic markers in craniopharyngioma, high-grade glioma, and other tumor types.
Researchers built a systematic map of protein-drug interactions to investigate the behaviors of cancer cells and the dependencies of treatment responses.
The study compared SARS-CoV-2 to SARS-CoV-1 and MERS to find viral commonalities, and combined the analyses with real-world clinical data to suggest treatments.
The researchers also developed a web-based tool based on the data they gathered that could help predict COVID-19 severity in patients.
The deal enables Genosity to add Olink's proteomics technology with next-generation sequencing readout to its repertoire of services.
Planned and ongoing studies will use standardized plasma protein profiling workflows to discover biomarkers for a range of conditions.
Using proteomic, phosphoproteomic, and genomic data, researchers uncovered informative features in primary and metastatic samples from almost 150 CRC cases in China.
In Genome Biology this week: software tools to spot methylation patterns, proteome-wide association study approach, and more.
In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.